Galibier Capital Management Ltd. Astrazeneca PLC Transaction History

Galibier Capital Management Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$59.26 - $71.14 $1.4 Million - $1.68 Million	-23,634 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$54.02 - $63.83 $296,191 - $349,979	-5,483 Reduced 18.83%	23,634 $1.38 Million
Q3 2021 Oct 20, 2021	SELL	$55.56 - $60.79 $11,112 - $12,158	-200 Reduced 0.68%	29,117 $1.75 Million
Q2 2021 Jul 20, 2021	SELL	$48.42 - $60.18 $11,330 - $14,082	-234 Reduced 0.79%	29,317 $1.76 Million
Q4 2020 Jan 19, 2021	BUY	$48.52 - $58.02 $218,340 - $261,090	4,500 Added 17.96%	29,551 $1.48 Million

Q3 2020 Oct 26, 2020	SELL	$53.07 - $61.1 $13.7 Million - $15.8 Million	-258,097 Reduced 91.15%	25,051 $1.37 Million
Q2 2020 Aug 05, 2020	BUY	$43.1 - $55.31 $303,251 - $389,161	7,036 Added 2.55%	283,148 $15 Million
Q1 2020 Apr 21, 2020	SELL	$37.79 - $51.33 $3.09 Million - $4.19 Million	-81,658 Reduced 22.82%	276,112 $12.3 Million
Q4 2019 Jan 14, 2020	BUY	$42.46 - $50.46 $12.8 Million - $15.2 Million	300,611 Added 525.92%	357,770 $17.8 Million
Q3 2019 Nov 08, 2019	BUY	$40.12 - $45.47 $456,726 - $517,630	11,384 Added 24.87%	57,159 $2.55 Million
Q2 2019 Aug 02, 2019	BUY	$37.28 - $41.68 $1.71 Million - $1.91 Million	45,775 New	45,775 $1.89 Million

1,248

477M

5.99M

5.24M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $240B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Galibier Capital Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Galibier Capital Management Ltd. with notifications on news.